Developing an AI-powered personalised medicine tool for hypertension: HYPERMARKER

Status: Ongoing

Hypertension, or high blood pressure, is a serious medical condition and the single biggest contributor to circulatory disease. It continues to dominate as one of the leading causes of death and morbidity globally, with high social and economic burden on patients and health care systems. Whilst many treatments for hypertension are available, control of blood pressure remains poor in most countries, with avoidable consequences such as heart attacks, strokes, kidney disease and dementia.

Project aims

The HYPERMARKER team will develop and test tools supported by artificial intelligence that allow clinicians to select the best treatment for each individual patient with high blood pressure.

In HYPERMARKER, patient cohorts from eleven European countries will provide data to develop the clinical decision support tool. Artificial intelligence approaches will be used to integrate this information with clinical factors, using deep learning methods to isolate what is most important to determining treatment for each patient. The tools will be validated and refined through an innovative randomized clinical trial across 4 countries, supported by patient and public engagement.

The HYPERMARKER consortium consists of 12 partners, including world leaders in health data science, patient advocacy and industry.